160 related articles for article (PubMed ID: 23928166)
1. Tuberculosis screening for long-term care: a cost-effectiveness analysis.
Verma G; Chuck AW; Jacobs P
Int J Tuberc Lung Dis; 2013 Sep; 17(9):1170-7. PubMed ID: 23928166
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection.
Deuffic-Burban S; Atsou K; Viget N; Melliez H; Bouvet E; Yazdanpanah Y
Int J Tuberc Lung Dis; 2010 Apr; 14(4):471-81. PubMed ID: 20202306
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.
Oxlade O; Schwartzman K; Menzies D
Int J Tuberc Lung Dis; 2007 Jan; 11(1):16-26. PubMed ID: 17217125
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of tuberculosis control strategies among immigrants and refugees.
Dasgupta K; Menzies D
Eur Respir J; 2005 Jun; 25(6):1107-16. PubMed ID: 15929967
[TBL] [Abstract][Full Text] [Related]
5. Moving toward tuberculosis elimination: implementation of statewide targeted tuberculin testing in Tennessee.
Cain KP; Garman KN; Laserson KF; Ferrousier-Davis OP; Miranda AG; Wells CD; Haley CA
Am J Respir Crit Care Med; 2012 Aug; 186(3):273-9. PubMed ID: 22561962
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries.
Hardy AB; Varma R; Collyns T; Moffitt SJ; Mullarkey C; Watson JP
Thorax; 2010 Feb; 65(2):178-80. PubMed ID: 19996345
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a school-based tuberculosis-screening program and associate investigation targeting recently immigrated children in a low-burden country.
Brassard P; Steensma C; Cadieux L; Lands LC
Pediatrics; 2006 Feb; 117(2):e148-56. PubMed ID: 16452324
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis.
Diel R; Wrighton-Smith P; Zellweger JP
Eur Respir J; 2007 Aug; 30(2):321-32. PubMed ID: 17504793
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry.
Flaherman VJ; Porco TC; Marseille E; Royce SE
Pediatrics; 2007 Jul; 120(1):90-9. PubMed ID: 17606566
[TBL] [Abstract][Full Text] [Related]
10. Use of the QuantiFERON-TB Gold test to confirm latent tuberculosis infection in a Canadian tuberculosis clinic.
Kunimoto D; Der E; Beckon A; Thomas L; Egedahl M; Beatch A; Williams G; Tyrrell G; Ahmed R; Brown N; Long R
Int J Tuberc Lung Dis; 2009 Jun; 13(6):726-30. PubMed ID: 19460248
[TBL] [Abstract][Full Text] [Related]
11. Direct costs of three models for the screening of latent tuberculosis infection.
Wrighton-Smith P; Zellweger JP
Eur Respir J; 2006 Jul; 28(1):45-50. PubMed ID: 16611659
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH
Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis.
Schwartzman K; Menzies D
Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):780-9. PubMed ID: 10712322
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of targeted and sequential screening strategies for latent tuberculosis.
Mancuso JD; Niebuhr DW; Frick KD; Keep LW; Anderson KM
Int J Tuberc Lung Dis; 2011 Sep; 15(9):1223-30, i. PubMed ID: 21943850
[TBL] [Abstract][Full Text] [Related]
15. Cost-optimisation of screening for latent tuberculosis in close contacts.
Diel R; Nienhaus A; Lange C; Schaberg T
Eur Respir J; 2006 Jul; 28(1):35-44. PubMed ID: 16571615
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts.
Marra F; Marra CA; Sadatsafavi M; Morán-Mendoza O; Cook V; Elwood RK; Morshed M; Brunham RC; Fitzgerald JM
Int J Tuberc Lung Dis; 2008 Dec; 12(12):1414-24. PubMed ID: 19017451
[TBL] [Abstract][Full Text] [Related]
17. A risk/cost analysis of alternative screening intervals for occupational tuberculosis infection.
Nicas M
Am Ind Hyg Assoc J; 1998 Feb; 59(2):104-12. PubMed ID: 9487664
[TBL] [Abstract][Full Text] [Related]
18. Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany.
Diel R; Schaberg T; Loddenkemper R; Welte T; Nienhaus A
Respir Med; 2009 Dec; 103(12):1838-53. PubMed ID: 19682884
[TBL] [Abstract][Full Text] [Related]
19. Costs of QuantiFERON-TB Gold versus tuberculin skin test in Spanish healthcare workers.
Linertová R; Alvarez-León EE; García-Pérez L; Serrano-Aguilar P
J Hosp Infect; 2010 May; 75(1):52-5. PubMed ID: 20307915
[TBL] [Abstract][Full Text] [Related]
20. Miniature chest radiograph screening for tuberculosis in jails: a cost-effectiveness analysis.
Jones TF; Schaffner W
Am J Respir Crit Care Med; 2001 Jul; 164(1):77-81. PubMed ID: 11435242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
